Home
 /
Papers
 /
Microbiology
 /
Systematic discovery of TIR-based immune signaling systems in bacteria
Preprint
Open access
Top 1% · Validated by QED

Systematic discovery of TIR-based immune signaling systems in bacteria

Erez Yirmiya, Azita Leavitt, Bohdana Hurieva +5 more
December 2025
 ·
bioRxiv
 ·
DOI 
10.64898/2025.12.03.692087
99
%
QED Score
QED Impressions

By proving that bacteria synthesize the same immune signals—canonical cADPR and 2′cADPR—as plants and humans, this work overturns assumptions of convergent evolution and establishes deep conservation of TIR-based immune logic across all life.

Run full QED analysis
Read paper
Save

QED claims analysis

Summary

Systematic genomic analysis reveals that TIR-based immune signaling systems are present in approximately 8% of bacterial genomes and comprise at least eleven distinct Thoeris types that utilize diverse immune signaling molecules—including 3'cADPR, the plant immune signal 2'cADPR, and the human immune signal canonical cADPR—to activate approximately 30 different effector proteins for antiphage defense, establishing that TIR-derived immune signals are conserved across bacteria, plants, and animals.

See full analysis
Main Claim 1 –

Diverse bacterial TIR defense systems encode ~30 predicted effectors

Main Claim 2 –

Fifteen new TIR systems confer antiphage defense via novel effectors

Supporting evidence

  • New Thoeris effectors oligomerize with positively charged signal-binding pockets
Main Claim 3 –

Type V and IX Thoeris TIRs produce 3′cADPR

Supporting evidence

  • B. thuringiensis type V responds to 3′cADPR; sponges inhibit
Main Claim 4 –

Type VI Thoeris uses 2′cADPR, conserved with plant immunity

Supporting evidence

  • Type VI arrests growth with 2′cADPR; sponges bypass defense
  • Mo Tad2 sequesters 2′cADPR for validating type VI signaling

Abstract

Toll/interleukin-1 receptor (TIR) domains are important for immune signaling across humans, plants and bacteria. These domains were recently found to produce immune signaling molecules in plant immunity as well as in a family of bacterial defense systems called Thoeris. Here, we systematically scanned bacterial defense islands to identify anti-phage defense systems involving TIR-mediated signaling. We detected numerous configurations of such systems in bacterial genomes, involving ∼30 different protein effectors predicted to respond to TIR-produced immune signals. We experimentally verified 15 new TIR-containing systems, showing that they provide defense against phages through effector protein domains not previously known as associated with immunity. Further biochemical analyses revealed bacterial Thoeris systems that generate 2′cADPR, an immune signaling molecule central to plant immunity. We also discover multiple types of Thoeris that drive antiphage defense via canonical cADPR, a signaling molecule known to mediate human innate immunity. Our studies show that TIR-based immune signaling systems exist in at least 8% of bacterial genomes, and suggest conservation of TIR-derived immune signals across the tree of life.

Related papers

How the QED Score works

QED Score is an AI-based quality metric for life science research. It rates each paper on two dimensions: originality (is the finding new and important?) and validity (does the evidence support the claims?). Author names and affiliations are removed before scoring. Each manuscript is broken down into its claims and the experiments behind them, and specialized AI agents then examine those claims for statistical rigor, consistency across figures, and contradictions with the existing literature. A verification layer re-checks every issue they flag. Scores are percentile ranks against all papers in the corpus. In a blinded study of papers where QED Score and journal rank disagreed, domain experts sided with QED Score in 75% of cases.
Read the methodology

Free access for academic researchers

Create your free QED account to validate your research, strengthen grant proposals, and uncover scientific insights.
We've sent you an access link.
Please check your inbox.

Didn't get your email? Check your spam folder or reach out to info@qedscience.com

Oops! Something went wrong while submitting the form.
Looking for QED for pharma, biotech or life science organizations?